Le Lézard
Classified in: Business
Subject: STH

Canadian Investment Regulatory Organization Trading Halt - VAGN


VANCOUVER, BC, Sept. 22, 2023 /CNW/ - The following issues have been halted by CIRO:

Company: Vegano Foods Inc.

CSE Symbol: VAGN

All Issues: Yes

Reason: Pending Company Contact

Halt Time (ET): 9:31 AM

CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Canadian Investment Regulatory Organization (CIRO) ? Halts/Resumptions


These press releases may also interest you

at 07:45
Oracle Hospitality today announced that it has signed an agreement with Choice Hotels International, one of the largest lodging franchisors in the world, to extend its AI-powered merchandising solution Oracle...

at 07:45
The following issues have been halted by CIRO Company: Fraser Mackenzie Accelerator Corp. TSX-Venture Symbol: FMAC.P All Issues: Yes Reason: Pending News Halt Time (ET): 7:37 AM CIRO can make a decision to impose a temporary suspension (halt) of...

at 07:43
The Winners Circle, an innovative rewards programme and loyalty platform for horse racing fans, is delighted to announce its partnership with Saffie Osborne, an esteemed British flat racing jockey with more than 200 race wins....

at 07:40
Avicanna Inc. ("Avicanna" or the "Company) a biopharmaceutical company focused on the development, manufacturing, and commercialization of...

at 07:35
Smith Douglas Homes Corp. ("Smith Douglas" or the "Company") today announced first quarter results for the three months ended March 31, 2024. Q1 2024 Results as compared to Q1 2023: Net new orders increased 15% to 765 Home closings increased...

at 07:35
Syros Pharmaceuticals , a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today reported financial results for the quarter ended March 31, 2024 and provided a corporate...



News published on and distributed by: